Microsoft Corporation <MSFT.O>: Oppenheimer raises target price to $570 from $515
MSFT•Related News
Vistagen Therapeutics Says Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VTGN•
Rhode Island Energy names Joe Curley vice president of electric operations
PPL•
GIBO Holdings director Ban You Shim files initial beneficial ownership statement
GIBO•
Claritev selected by GDIT to support CDC World Trade Center Health Program provider network
CTEV•
Goldman in talks to buy $37 billion credit firm Palmer Square - Bloomberg News
GS•